117 related articles for article (PubMed ID: 8819344)
21. Application of qualitative and quantitative uncertainty assessment tools in developing ranges of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wikoff D; Haws L; Ring C; Budinsky R
J Appl Toxicol; 2019 Sep; 39(9):1293-1310. PubMed ID: 31257608
[TBL] [Abstract][Full Text] [Related]
22. Effects of aging on resistance to Trichinella spiralis infection in rodents exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Luebke RW; Copeland CB; Andrews DL
Toxicology; 1999 Aug; 136(1):15-26. PubMed ID: 10499847
[TBL] [Abstract][Full Text] [Related]
23. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
24. Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD).
Kociba RJ; Schwetz BA
Drug Metab Rev; 1982; 13(3):387-406. PubMed ID: 6213397
[TBL] [Abstract][Full Text] [Related]
25. Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
Schrenk D; Buchmann A; Dietz K; Lipp HP; Brunner H; Sirma H; Münzel P; Hagenmaier H; Gebhardt R; Bock KW
Carcinogenesis; 1994 Mar; 15(3):509-15. PubMed ID: 8118936
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
27. Suppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the high-affinity antibody response in C57BL/6 mice.
Inouye K; Ito T; Fujimaki H; Takahashi Y; Takemori T; Pan X; Tohyama C; Nohara K
Toxicol Sci; 2003 Aug; 74(2):315-24. PubMed ID: 12773764
[TBL] [Abstract][Full Text] [Related]
28. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
[TBL] [Abstract][Full Text] [Related]
30. Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part II. Biochemical effects.
Viluksela M; Stahl BU; Birnbaum LS; Rozman KK
Toxicol Appl Pharmacol; 1997 Oct; 146(2):217-26. PubMed ID: 9344889
[TBL] [Abstract][Full Text] [Related]
31. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats.
Fan F; Wierda D; Rozman KK
Toxicology; 1996 Jan; 106(1-3):221-8. PubMed ID: 8571394
[TBL] [Abstract][Full Text] [Related]
32. Dioxin hepatic carcinogenesis: biologically motivated modeling and risk assessment.
Mills JJ; Andersen ME
Toxicol Lett; 1993 May; 68(1-2):177-89. PubMed ID: 8516763
[TBL] [Abstract][Full Text] [Related]
33. Development of a Range of Plausible Noncancer Toxicity Values for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Based on Effects on Sperm Count: Application of Systematic Review Methods and Quantitative Integration of Dose Response Using Meta-Regression.
Wikoff DS; Urban JD; Ring C; Britt J; Fitch S; Budinsky R; Haws LC
Toxicol Sci; 2021 Jan; 179(2):162-182. PubMed ID: 33306106
[TBL] [Abstract][Full Text] [Related]
34. Aroclor 1254 as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: effects on enzyme induction and immunotoxicity.
Bannister R; Davis D; Zacharewski T; Tizard I; Safe S
Toxicology; 1987 Oct; 46(1):29-42. PubMed ID: 3116725
[TBL] [Abstract][Full Text] [Related]
35. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) effects on hepatic microsomal cytochrome P-448-mediated enzyme activities.
Kitchin KT; Woods JS
Toxicol Appl Pharmacol; 1979 Mar; 47(3):537-46. PubMed ID: 442093
[No Abstract] [Full Text] [Related]
36. Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species.
Fletcher N; Hanberg A; Håkansson H
Toxicol Sci; 2001 Jul; 62(1):166-75. PubMed ID: 11399804
[TBL] [Abstract][Full Text] [Related]
37. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice.
Fujimaki H; Nohara K; Kobayashi T; Suzuki K; Eguchi-Kasai K; Tsukumo S; Kijima M; Tohyama C
Toxicol Sci; 2002 Mar; 66(1):117-24. PubMed ID: 11861978
[TBL] [Abstract][Full Text] [Related]
38. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice.
Lawrence BP; Kerkvliet NI
Toxicol Sci; 1998 Mar; 42(1):13-22. PubMed ID: 9538043
[TBL] [Abstract][Full Text] [Related]
39. Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model.
Thomaseth K; Salvan A
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):743-53. PubMed ID: 9599726
[TBL] [Abstract][Full Text] [Related]
40. Opposite effects of 2,2',4,4',5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antibody response to sheep erythrocytes in mice.
Smialowicz RJ; DeVito MJ; Riddle MM; Williams WC; Birnbaum LS
Fundam Appl Toxicol; 1997 Jun; 37(2):141-9. PubMed ID: 9242587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
